GLP-1

GLP-1 Weight Management Program | Nurse Practitioner Prescribed | Tri-Health Wellness Centre
Book Consultation
Now Accepting New Patients

GLP-1 Weight Management
Prescribed by Our Nurse Practitioner

Personalized, medically supervised GLP-1 therapy (Wegovy®, Zepbound®, Saxenda®) combined with Tri-Health’s integrative approach for sustainable results in Vaughan & the GTA.

Book with Nurse Practitioner Call (905) 605-9355
15–22%
Average weight loss
in clinical trials
NP-Led
Expert prescribing
& ongoing support
3 Options
Health Canada
approved agents

Start Your Journey Today

Step 1 is a comprehensive consultation with our Nurse Practitioner to determine if GLP-1 therapy is right for you.

HK
Hardeep Kaur, NP Nurse Practitioner • Prescribing Clinician

Booking this Initial Primary Care visit provides the history and information needed to start the process and answer all your questions.

Book with Nurse Hardeep →

Secure online booking via Jane

Treatment Options

Discussing Your GLP-1 Choices

We prescribe only Health Canada-approved medications for weight management. Your Nurse Practitioner will help select the best option based on your health profile, goals, preference for injection frequency, and insurance coverage.

💉

Wegovy®

Semaglutide (weekly injection)

The most studied GLP-1 for weight management. Strong evidence for both weight loss and cardiovascular protection.

  • Once-weekly subcutaneous injection
  • Proven CV risk reduction (SELECT trial)
  • Gradual titration for tolerability
  • Excellent for patients prioritizing heart health
~15% average body weight loss

Typical monthly cost in Canada: $400–$570

⚡

Zepbound®

Tirzepatide (weekly injection)

Dual GIP/GLP-1 agonist — currently the most effective agent for weight loss in clinical trials.

  • Once-weekly dual-agonist injection
  • Highest average weight loss in head-to-head data
  • Also improves metabolic markers strongly
  • Great for those seeking maximum results
~20–22% average body weight loss

Typical monthly cost in Canada: $300–$540+

📅

Saxenda®

Liraglutide (daily injection)

Daily GLP-1 option with a long safety track record. Useful when weekly options are not preferred or covered.

  • Once-daily subcutaneous injection
  • Established safety profile over many years
  • May be preferred for certain coverage situations
  • Good entry point for some patients
~8–10% average body weight loss

Typical monthly cost in Canada: $450–$600

How We Choose Together

There is no single “best” medication for everyone. Your Nurse Practitioner will discuss:

• Efficacy goals

Desired % weight loss and speed

• Injection preference

Weekly vs daily convenience

• Cardiometabolic risk

Heart, kidney, liver considerations

• Coverage & cost

Insurance, private pay, options

Note: Ozempic® (semaglutide) may be discussed for off-label weight management in some cases, but we prioritize Health Canada-approved indications (Wegovy, Zepbound, Saxenda) when possible.

Evidence-Based

Clinical Studies & Real Results

We base our recommendations on the strongest available evidence from large randomized trials and recent network meta-analyses (2025–2026).

STEP 1 Trial • Semaglutide 2.4 mg

Wegovy® Landmark Trial

−14.9%

Mean body weight reduction at 68 weeks vs 2.4% with placebo + lifestyle. Over two-thirds of participants lost ≥10% of body weight. Foundation for modern GLP-1 weight management.

SURMOUNT-1 Trial • Tirzepatide

Zepbound® Highest Efficacy

−20.9%

At the 15 mg dose over 72 weeks. The highest average weight loss among currently available agents. Significant improvements in waist circumference, blood pressure, and lipids.

SURMOUNT-5 Head-to-Head 2025/26

Tirzepatide vs Semaglutide

20.2% vs 13.7%

First large direct comparison: tirzepatide produced greater weight loss than semaglutide at comparable time points, helping guide choice when maximum reduction is the priority.

Network Meta-Analysis 2026 (BMJ / Annals)

Comparative Effectiveness

262 trials

~100,000 participants. Tirzepatide and CagriSema led weight loss (~14.9%). Subcutaneous semaglutide uniquely reduced all-cause mortality (RR 0.81) and myocardial infarction risk. Supports individualized selection.

SELECT Trial • Semaglutide CVOT

Cardiovascular Protection

20% ↓ MACE

Semaglutide reduced major adverse cardiovascular events by 20% in people with overweight/obesity and established CVD — independent of diabetes. Key reason many clinicians prefer Wegovy for higher-risk patients.

Real-World & Safety Data

Tolerability & Monitoring

GI AEs common

Nausea, vomiting, constipation occur most during titration (usually mild–moderate and transient). Discontinuation rates are manageable with slow titration, dietary guidance, and close NP follow-up — our standard approach at Tri-Health.

All recommendations are personalized. Results vary. These medications work best when combined with nutrition, movement, sleep, and behavioural support — which is why we integrate them into Tri-Health’s holistic model.

Simple Path

How Our Program Works

Clear steps from first contact to long-term success, all under Nurse Practitioner care.

1

Book Consultation

Schedule your Initial Primary Care visit with Nurse Practitioner Hardeep Kaur using our secure Jane booking link.

2

Comprehensive Assessment

Full history, BMI/comorbidity review, labs (if needed), goals discussion, and eligibility screening.

3

Personalized Prescription

Choose among Wegovy, Zepbound or Saxenda. Receive titration plan, education, and side-effect management strategies.

4

Ongoing Support

Regular follow-ups, dose adjustments, lifestyle integration with our team, and monitoring for safety & results.

Why Tri-Health

More Than Just a Prescription

GLP-1s are powerful tools — we surround them with the support that makes results last.

🩺

NP Expertise

Prescribing authority, careful screening, and longitudinal care from a Nurse Practitioner who knows the science and the patient.

🥗

Integrative Nutrition

Pair medication with our Youbiotic Diet principles, protein focus, and gut-health strategies to protect muscle and results.

🔬

Metabolic Monitoring

Labs, InBody scans, and ongoing assessment of inflammation, insulin sensitivity, and body composition.

🤝

Whole-Team Care

Access to NDs, RNs, and lifestyle support so you never feel like you’re on a medication alone.

Eligibility

Is GLP-1 Therapy Right for You?

At Tri-Health we perform a thorough assessment. You may be a candidate if you:

  • Have a BMI ≥ 30, or BMI ≥ 27 with weight-related comorbidities
  • Have struggled with weight despite consistent lifestyle efforts
  • Are ready for a medically supervised, long-term approach
  • Have no absolute contraindications (e.g., personal/family history of medullary thyroid carcinoma, MEN2, etc.)

What We Offer

  • Complimentary 15-minute discovery calls
  • Comprehensive initial assessments (including bloodwork review)
  • Ongoing support from a multidisciplinary team
  • Clear education on titration, side effects & lifestyle synergy
  • Focus on sustainable, health-first outcomes
Check Your Eligibility
Questions Answered

Frequently Asked Questions

Compiled with insights from our Nurse Practitioner. For personal advice, book a consultation or call us.

We prescribe Wegovy® (semaglutide), Saxenda® (liraglutide), and Zepbound® (tirzepatide) — all Health Canada approved for weight management. Ozempic may be discussed in select off-label situations, but we prioritize the approved weight-loss indications.
Approximate monthly costs in Canada (subject to change and pharmacy): Wegovy $400–$570, Saxenda $450–$600, Zepbound/Mounjaro $300–$540+. Insurance coverage varies widely and is more likely for medications with an approved obesity indication. We help you navigate coverage options.
Clinical trials show average losses of ~15% with semaglutide (Wegovy) and ~20–22% with tirzepatide (Zepbound) over 68–72 weeks when combined with lifestyle changes. Individual results vary based on adherence, starting weight, dose reached, and concurrent lifestyle support. Our program emphasizes realistic, sustainable progress.
Gastrointestinal effects (nausea, vomiting, diarrhea, constipation, reduced appetite) are most common, especially during dose escalation. They are usually mild to moderate and improve with time, slower titration, smaller meals, and adequate protein/hydration. Serious risks (pancreatitis, gallbladder issues, thyroid C-cell tumours in animals) are rare; we screen carefully and monitor closely.
Obesity is a chronic condition. Many people benefit from long-term therapy. When stopping, weight regain is common without strong lifestyle foundations. We work with you on maintenance strategies, possible dose reduction, and the full suite of Tri-Health supports (nutrition, movement, sleep, stress, gut health) so results last.
Book an Initial Primary Care visit with Nurse Practitioner Hardeep Kaur using our secure online booking link (or call 905-605-9355). Bring any recent labs if available. We will assess eligibility, discuss options, and create a plan together.

Ready to Begin Your GLP-1 Journey?

Take the first step with a consultation with our Nurse Practitioner. Evidence-based care, personalized options, and the full support of the Tri-Health team.

Book with Nurse Hardeep Now or call (905) 605-9355

Vaughan / Woodbridge • Greater Toronto Area • Integrative Wellness